| Beaver Dam Nursing & Rehab Center, Inc | |
| 1595 S Us Highway 231, Beaver Dam, Kentucky 42320 | |
| (270) 274-9646 | |
| Name | Beaver Dam Nursing & Rehab Center, Inc |
|---|---|
| Location | 1595 S Us Highway 231, Beaver Dam, Kentucky |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 58 |
| Occupancy Rate | 93.62% |
| Medicare ID (CCN) | 185334 |
| Legal Business Name | Beaver Dam Nursing & Rehab Center, Inc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1538321781 |
| Organization Name | BEAVER DAM HEALTH CARE MANOR INC |
| Doing Business As | BEAVER DAM HEALTH CARE MANOR |
| Address | 1595 Us Highway 231 S, Beaver Dam, KY 42320 |
| Phone Number | 270-274-9646 |
News Archive
A discovery by Monash University scientists could see humble cotton thread emerge as a core material in low-cost 'lab-on-chip' devices capable of detecting diseases such as kidney failure and diabetes.
Cempra Inc., a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases,today announced that data will be presented at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), in London, March 31 to April 3,demonstrating CEM-101's (solithromycin's) efficacy to be comparable to levofloxacin in a Phase 2 trial of patients with community-acquired bacterial infections.
Optimer Pharmaceuticals, Inc. today announced the presentation of new data from fidaxomicin's North American phase 3 study at the 47th Annual Meeting of the Infectious Diseases Society of America (IDSA) in Philadelphia, PA.
Global carbon dioxide emissions increased by a record 5.9 per cent in 2010 following the dampening effect of the 2008-2009 Global Financial Crisis (GFC), according to scientists working with the Global Carbon Project.
Researchers at the Monell Chemical Senses Center have identified a genetically-transmitted metabolic defect that can lead to obesity in some individuals.
› Verified 6 days ago
| NPI Number | 1669543716 |
| Organization Name | BEAVER DAM NURSING & REHAB CENTER, INC |
| Address | 1595 Us Highway 231 S, Beaver Dam, KY 42320 |
| Phone Number | 270-274-9646 |
News Archive
A discovery by Monash University scientists could see humble cotton thread emerge as a core material in low-cost 'lab-on-chip' devices capable of detecting diseases such as kidney failure and diabetes.
Cempra Inc., a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases,today announced that data will be presented at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), in London, March 31 to April 3,demonstrating CEM-101's (solithromycin's) efficacy to be comparable to levofloxacin in a Phase 2 trial of patients with community-acquired bacterial infections.
Optimer Pharmaceuticals, Inc. today announced the presentation of new data from fidaxomicin's North American phase 3 study at the 47th Annual Meeting of the Infectious Diseases Society of America (IDSA) in Philadelphia, PA.
Global carbon dioxide emissions increased by a record 5.9 per cent in 2010 following the dampening effect of the 2008-2009 Global Financial Crisis (GFC), according to scientists working with the Global Carbon Project.
Researchers at the Monell Chemical Senses Center have identified a genetically-transmitted metabolic defect that can lead to obesity in some individuals.
› Verified 6 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
A discovery by Monash University scientists could see humble cotton thread emerge as a core material in low-cost 'lab-on-chip' devices capable of detecting diseases such as kidney failure and diabetes.
Cempra Inc., a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases,today announced that data will be presented at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), in London, March 31 to April 3,demonstrating CEM-101's (solithromycin's) efficacy to be comparable to levofloxacin in a Phase 2 trial of patients with community-acquired bacterial infections.
Optimer Pharmaceuticals, Inc. today announced the presentation of new data from fidaxomicin's North American phase 3 study at the 47th Annual Meeting of the Infectious Diseases Society of America (IDSA) in Philadelphia, PA.
Global carbon dioxide emissions increased by a record 5.9 per cent in 2010 following the dampening effect of the 2008-2009 Global Financial Crisis (GFC), according to scientists working with the Global Carbon Project.
Researchers at the Monell Chemical Senses Center have identified a genetically-transmitted metabolic defect that can lead to obesity in some individuals.
› Verified 6 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 2 |
| Total Amount of Fines in Dollars | $26843 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 2 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 14.87 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 7.39 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 59.38 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 6.8 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 3.17 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 3.85 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 4.48 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 92.54 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 21.28 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 69.41 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 13.95 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 40.11 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 47.98 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 6.62 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 90.22 | 95.98 |